Delivery Order SPE2DB20D3303-SPE2DB24FZ3S5
Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Eliquis 5 mg tablets. The $7,018.95 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of July 2, 2024. The contract is not set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,277.96 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation indicated. The company holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order, valued at $7,029.64, is for the supply of Eliquis 5 mg tablets. The contract is a firm fixed price arrangement with an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Eliquis 5 mg tablets. The contract, valued at $17,951.80, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,865.14 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $39,819.99 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of Eliquis 5 mg tablets, a pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The contract, valued at $16,483.58, is a firm fixed-price delivery order with a completion date of June 21, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $10,417.54 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This contract award to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of Eliquis 2.5 mg tablets to the U.S. government. The award, valued at $1,900.08, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $13,653.65, is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FZ3S5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) to supply the pharmaceutical product Eliquis 5 mg tablets. The $14,291.13 firm fixed-price delivery order has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The company also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide.
Generated 7/4/24, 10:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 4/4/24 |